A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?

AIM: To determine the efficacy and safety of inactivated SARS-CoV-2 vaccine (BBIBP-CorV) in patients with breast cancer. METHODS: In this multi- institutional cohort study, a total of 160 breast cancer patients (mean age of 50.01 ± 11.5 years old) were assessed for the SARS-CoV-2 Anti-Spike IgG and...

Descripción completa

Detalles Bibliográficos
Autores principales: Joudi, Maryam, Moradi Binabaj, Maryam, Porouhan, Pejman, PeyroShabany, Babak, Tabasi, Mohsen, Fazilat-Panah, Danial, Khajeh, Mahtab, Mehrabian, Arezoo, Dehghani, Mansoureh, Welsh, James S., Keykhosravi, Batol, Akbari Yazdi, Azam, Ariamanesh, Mona, Ghasemi, Ahmad, Ferns, Gordon, Javadinia, Seyed Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923352/
https://www.ncbi.nlm.nih.gov/pubmed/35299966
http://dx.doi.org/10.3389/fendo.2022.798975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923352/
https://www.ncbi.nlm.nih.gov/pubmed/35299966
http://dx.doi.org/10.3389/fendo.2022.798975

Ejemplares similares